Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors

R. Plummer; R. E. Sanborn; E. G.E. de Vries; P. Lorusso; H. T. Arkenau; N. Uboha; J. Wydmanski; M. J. Fidler; V. Boni; J. Garcia-Corbacho; R. Humphrey; M. Will; K. A. Autio; A. B. El-Khoueiry; C. W. Menke-van der Houven van Oordt; F. Thistlethwaite

doi:https://doi.org/10.1093/annonc/mdy279.423

Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors

R. Plummer, R. E. Sanborn, E. G.E. de Vries, P. Lorusso, H. T. Arkenau, N. Uboha, J. Wydmanski, M. J. Fidler, V. Boni, J. Garcia-Corbacho, R. Humphrey, M. Will, K. A. Autio, A. B. El-Khoueiry, C. W. Menke-van der Houven van Oordt, F. Thistlethwaite

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	viii143
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy279.423
Publication status	Published - 1 Oct 2018

Access to Document

https://doi.org/10.1093/annonc/mdy279.423

Cite this

Plummer, R., Sanborn, R. E., de Vries, E. G. E., Lorusso, P., Arkenau, H. T., Uboha, N., Wydmanski, J., Fidler, M. J., Boni, V., Garcia-Corbacho, J., Humphrey, R., Will, M., Autio, K. A., El-Khoueiry, A. B., Menke-van der Houven van Oordt, C. W., & Thistlethwaite, F. (2018). Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii143. https://doi.org/10.1093/annonc/mdy279.423

Plummer, R. ; Sanborn, R. E. ; de Vries, E. G.E. et al. / Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors. In: Annals of oncology : official journal of the European Society for Medical Oncology. 2018 ; Vol. 29. pp. viii143.

@article{475e2a5328844f25a6e38e2c67f57bc4,

title = "Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors",

author = "R. Plummer and Sanborn, {R. E.} and {de Vries}, {E. G.E.} and P. Lorusso and Arkenau, {H. T.} and N. Uboha and J. Wydmanski and Fidler, {M. J.} and V. Boni and J. Garcia-Corbacho and R. Humphrey and M. Will and Autio, {K. A.} and El-Khoueiry, {A. B.} and {Menke-van der Houven van Oordt}, {C. W.} and F. Thistlethwaite",

year = "2018",

month = oct,

day = "1",

doi = "https://doi.org/10.1093/annonc/mdy279.423",

language = "English",

volume = "29",

pages = "viii143",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Plummer, R, Sanborn, RE, de Vries, EGE, Lorusso, P, Arkenau, HT, Uboha, N, Wydmanski, J, Fidler, MJ, Boni, V, Garcia-Corbacho, J, Humphrey, R, Will, M, Autio, KA, El-Khoueiry, AB, Menke-van der Houven van Oordt, CW & Thistlethwaite, F 2018, 'Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii143. https://doi.org/10.1093/annonc/mdy279.423

Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors. / Plummer, R.; Sanborn, R. E.; de Vries, E. G.E. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii143.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors

AU - Plummer, R.

AU - Sanborn, R. E.

AU - de Vries, E. G.E.

AU - Lorusso, P.

AU - Arkenau, H. T.

AU - Uboha, N.

AU - Wydmanski, J.

AU - Fidler, M. J.

AU - Boni, V.

AU - Garcia-Corbacho, J.

AU - Humphrey, R.

AU - Will, M.

AU - Autio, K. A.

AU - El-Khoueiry, A. B.

AU - Menke-van der Houven van Oordt, C. W.

AU - Thistlethwaite, F.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85079356890&partnerID=8YFLogxK

U2 - https://doi.org/10.1093/annonc/mdy279.423

DO - https://doi.org/10.1093/annonc/mdy279.423

M3 - Article

C2 - 32136230

SN - 0923-7534

VL - 29

SP - viii143

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Plummer R, Sanborn RE, de Vries EGE, Lorusso P, Arkenau HT, Uboha N et al. Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Oct 1;29:viii143. doi: https://doi.org/10.1093/annonc/mdy279.423

Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors

Access to Document

Other files and links

Cite this